The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

Puder et al., therefore, investigated the relationships between serum estrogen concentrations, exercise level, body composition and leptin concentrations, in young, premenopausal women.

Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill. A person takes this drug daily before bed, even if they do not intend to ...

The cohort was comprised of: 22 participants who had premenopausal bilateral oophorectomy (PBO) before age 40 43 participants who had PBO between the ages of 40 and 45 39 participants who had PBO ...

No improvement in overall survival (OS) was observed with palbociclib (Verzenio) plus endocrine therapy versus capecitabine ...

Postmenopausal women with CSA were associated with an increased risk of developing ACPA-negative IA and progressing to RA.